HEADER OXIDOREDUCTASE 09-JUN-06 2H9I TITLE MYCOBACTERIUM TUBERCULOSIS INHA BOUND WITH ETH-NAD ADDUCT COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NADH- DEPENDENT ENOYL-ACP REDUCTASE; COMPND 5 EC: 1.3.1.9; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 1773; SOURCE 4 GENE: INHA; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS INHA, ETHIONAMIDE, ETH, TUBERCULOSIS, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR F.WANG,J.C.SACCHETTINI REVDAT 5 20-OCT-21 2H9I 1 REMARK SEQADV REVDAT 4 13-JUL-11 2H9I 1 VERSN REVDAT 3 24-FEB-09 2H9I 1 VERSN REVDAT 2 06-FEB-07 2H9I 1 JRNL REVDAT 1 30-JAN-07 2H9I 0 JRNL AUTH F.WANG,R.LANGLEY,G.GULTEN,L.G.DOVER,G.S.BESRA,W.R.JACOBS, JRNL AUTH 2 J.C.SACCHETTINI JRNL TITL MECHANISM OF THIOAMIDE DRUG ACTION AGAINST TUBERCULOSIS AND JRNL TITL 2 LEPROSY. JRNL REF J.EXP.MED. V. 204 73 2007 JRNL REFN ISSN 0022-1007 JRNL PMID 17227913 JRNL DOI 10.1084/JEM.20062100 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.98 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 44255.090 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.0 REMARK 3 NUMBER OF REFLECTIONS : 19820 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.233 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1936 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.80 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2649 REMARK 3 BIN R VALUE (WORKING SET) : 0.3440 REMARK 3 BIN FREE R VALUE : 0.3480 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 296 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.020 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1993 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 54 REMARK 3 SOLVENT ATOMS : 34 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 9.87000 REMARK 3 B22 (A**2) : 9.87000 REMARK 3 B33 (A**2) : -19.74000 REMARK 3 B12 (A**2) : 17.17000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.32 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.38 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.020 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.31 REMARK 3 BSOL : 30.61 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : EAD.PAR REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : EAD.TOP REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2H9I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1000038098. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 121 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : ADSC REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20969 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1ENY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 12% MDP, 4% DMSO, 0.1M HEPES, 0.025M REMARK 280 SODIUM CITRATE, PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 62 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+2/3 REMARK 290 6555 X-Y,X,Z+1/3 REMARK 290 7555 Y,X,-Z+2/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+1/3 REMARK 290 10555 -Y,-X,-Z+2/3 REMARK 290 11555 -X+Y,Y,-Z REMARK 290 12555 X,X-Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 93.61333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 46.80667 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 93.61333 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 46.80667 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 93.61333 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 46.80667 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 93.61333 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 46.80667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A HEXAMER GENERATED FROM THE REMARK 300 MONOMER IN THE ASYMMETRIC UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 20190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 33630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -102.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -48.96700 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 84.81333 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 46.80667 REMARK 350 BIOMT1 4 0.500000 0.866025 0.000000 -48.96700 REMARK 350 BIOMT2 4 0.866025 -0.500000 0.000000 84.81333 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 46.80667 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 16 -35.21 -133.00 REMARK 500 PHE A 41 -92.82 -69.62 REMARK 500 ARG A 43 67.19 -104.11 REMARK 500 ALA A 157 -55.24 70.60 REMARK 500 ASN A 159 -114.25 29.43 REMARK 500 SER A 247 -169.78 -76.94 REMARK 500 ALA A 260 73.10 -114.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EAD A 300 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ZID RELATED DB: PDB REMARK 900 LONG FATTY ACID CHAIN ENOYL-ACP REDUCTASE (INHA) IN COMPLEX WITH AN REMARK 900 ISONICOTINIC-ACYL-NADH INHIBITOR DBREF 2H9I A 3 269 UNP P0A5Y6 INHA_MYCTU 3 269 SEQADV 2H9I ALA A 2 UNP P0A5Y6 ENGINEERED MUTATION SEQRES 1 A 268 ALA GLY LEU LEU ASP GLY LYS ARG ILE LEU VAL SER GLY SEQRES 2 A 268 ILE ILE THR ASP SER SER ILE ALA PHE HIS ILE ALA ARG SEQRES 3 A 268 VAL ALA GLN GLU GLN GLY ALA GLN LEU VAL LEU THR GLY SEQRES 4 A 268 PHE ASP ARG LEU ARG LEU ILE GLN ARG ILE THR ASP ARG SEQRES 5 A 268 LEU PRO ALA LYS ALA PRO LEU LEU GLU LEU ASP VAL GLN SEQRES 6 A 268 ASN GLU GLU HIS LEU ALA SER LEU ALA GLY ARG VAL THR SEQRES 7 A 268 GLU ALA ILE GLY ALA GLY ASN LYS LEU ASP GLY VAL VAL SEQRES 8 A 268 HIS SER ILE GLY PHE MET PRO GLN THR GLY MET GLY ILE SEQRES 9 A 268 ASN PRO PHE PHE ASP ALA PRO TYR ALA ASP VAL SER LYS SEQRES 10 A 268 GLY ILE HIS ILE SER ALA TYR SER TYR ALA SER MET ALA SEQRES 11 A 268 LYS ALA LEU LEU PRO ILE MET ASN PRO GLY GLY SER ILE SEQRES 12 A 268 VAL GLY MET ASP PHE ASP PRO SER ARG ALA MET PRO ALA SEQRES 13 A 268 TYR ASN TRP MET THR VAL ALA LYS SER ALA LEU GLU SER SEQRES 14 A 268 VAL ASN ARG PHE VAL ALA ARG GLU ALA GLY LYS TYR GLY SEQRES 15 A 268 VAL ARG SER ASN LEU VAL ALA ALA GLY PRO ILE ARG THR SEQRES 16 A 268 LEU ALA MET SER ALA ILE VAL GLY GLY ALA LEU GLY GLU SEQRES 17 A 268 GLU ALA GLY ALA GLN ILE GLN LEU LEU GLU GLU GLY TRP SEQRES 18 A 268 ASP GLN ARG ALA PRO ILE GLY TRP ASN MET LYS ASP ALA SEQRES 19 A 268 THR PRO VAL ALA LYS THR VAL CYS ALA LEU LEU SER ASP SEQRES 20 A 268 TRP LEU PRO ALA THR THR GLY ASP ILE ILE TYR ALA ASP SEQRES 21 A 268 GLY GLY ALA HIS THR GLN LEU LEU HET EAD A 300 54 HETNAM EAD {(2R,3S,4R,5R)-5-[(4S)-3-(AMINOCARBONYL)-4-(2- HETNAM 2 EAD ETHYLISONICOTINOYL)PYRIDIN-1(4H)-YL]-3,4- HETNAM 3 EAD DIHYDROXYTETRAHYDROFURAN-2-YL}METHYL [(2R,3S,4R,5R)-5- HETNAM 4 EAD (6-AMINO-9H-PURIN-9-YL)-3,4-DIHYDROXYTETRAHYDROFURAN- HETNAM 5 EAD 2-YL]METHYL DIHYDROGEN DIPHOSPHATE HETSYN EAD 2-ETHYL-ISONICOTINIC-ACYL-NICOTINAMIDE-ADENINE HETSYN 2 EAD DINUCLEOTIDE FORMUL 2 EAD C29 H36 N8 O15 P2 FORMUL 3 HOH *34(H2 O) HELIX 1 1 SER A 20 GLN A 32 1 13 HELIX 2 2 ARG A 43 ASP A 52 1 10 HELIX 3 3 ASN A 67 GLY A 83 1 17 HELIX 4 4 PRO A 99 MET A 103 5 5 HELIX 5 5 PRO A 107 ALA A 111 5 5 HELIX 6 6 PRO A 112 ALA A 124 1 13 HELIX 7 7 ALA A 124 LEU A 135 1 12 HELIX 8 8 TYR A 158 GLY A 180 1 23 HELIX 9 9 LYS A 181 GLY A 183 5 3 HELIX 10 10 THR A 196 GLY A 204 1 9 HELIX 11 11 GLY A 208 ALA A 226 1 19 HELIX 12 12 ALA A 235 SER A 247 1 13 HELIX 13 13 GLY A 263 GLN A 267 5 5 SHEET 1 A 7 LEU A 60 GLU A 62 0 SHEET 2 A 7 GLN A 35 GLY A 40 1 N LEU A 38 O LEU A 61 SHEET 3 A 7 ARG A 9 VAL A 12 1 N ILE A 10 O GLN A 35 SHEET 4 A 7 LEU A 88 HIS A 93 1 O ASP A 89 N ARG A 9 SHEET 5 A 7 MET A 138 ASP A 148 1 O VAL A 145 N HIS A 93 SHEET 6 A 7 ARG A 185 ALA A 191 1 O ARG A 185 N ILE A 144 SHEET 7 A 7 ASP A 256 ALA A 260 1 O ILE A 258 N LEU A 188 SITE 1 AC1 31 GLY A 14 ILE A 15 ILE A 16 SER A 20 SITE 2 AC1 31 ILE A 21 PHE A 41 LEU A 63 ASP A 64 SITE 3 AC1 31 VAL A 65 SER A 94 ILE A 95 GLY A 96 SITE 4 AC1 31 ILE A 122 MET A 147 ASP A 148 PHE A 149 SITE 5 AC1 31 MET A 155 TYR A 158 LYS A 165 ALA A 191 SITE 6 AC1 31 GLY A 192 PRO A 193 ILE A 194 THR A 196 SITE 7 AC1 31 MET A 199 TRP A 222 HOH A 302 HOH A 315 SITE 8 AC1 31 HOH A 320 HOH A 325 HOH A 330 CRYST1 97.934 97.934 140.420 90.00 90.00 120.00 P 62 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010211 0.005895 0.000000 0.00000 SCALE2 0.000000 0.011791 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007121 0.00000 MASTER 297 0 1 13 7 0 8 6 0 0 0 21 END